CENTURY ALUMINUM CO
Business
CENTURY ALUMINUM CO is a global producer of primary aluminum operating reduction facilities (smelters) in the United States and Iceland and holding upstream and ancillary assets. It produces standard‑grade and value‑added primary aluminum products, including ingot, billet, and primary foundry alloys, offers Natur‑Al low‑carbon products, and manufactures carbon anodes while sourcing alumina through its 55% interest in Jamalco. The company operates one reportable segment—primary aluminum—with smelters at Grundartangi (Iceland), Hawesville, Sebree and Mt. Holly (U.S.), a Vlissingen anode plant (Netherlands) and the Jamalco JV (Jamaica). Products are sold into U.S. and European markets under commercial contracts, LME‑linked pricing and regional/value‑added premiums.
Summary from filing dated 2025-03-03
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total net sales | 2,528 | 2,220 | 2,185 | 2,777 | 2,213 | |
| Cost of Goods Sold | 2,272 | 2,048 | 2,098 | 2,731 | 2,088 | |
| Gross profit | 256 | 172 | 88 | 47 | 124 | |
| Selling, general and administrative expenses | 80 | 57 | 44 | 38 | 58 | |
| Other operating expenses - net | 18 | 7 | 16 | 0 | 600,000 | |
| Operating income | 158 | 108 | 28 | −150 | 66 | |
| Interest income | 9 | 2 | 2 | 500,000 | 800,000 | |
| Net gain (loss) on forward and derivative contracts | −95 | 2 | 62 | 197 | −212 | |
| Loss on early extinguishment of debt | −8 | 0 | 0 | 0 | −25 | |
| Bargain purchase gain | 0 | 246 | 0 | 0 | — | |
| Other expense - net | −15 | −6 | −3 | 15 | 3 | |
| Income (loss) before income taxes | 3 | 310 | −71 | 33 | −198 | |
| Income tax benefit (expense) | 13 | −3 | 15 | −47 | 31 | |
| Income (loss) before equity in earnings of joint ventures | 16 | 307 | −57 | −14 | −167 | |
| Equity in earnings (losses) of joint ventures | 0 | 100,000 | −100,000 | −100,000 | −100,000 | |
| Net income (loss) | 16 | 307 | −57 | −14 | −167 | |
| Net loss attributable to noncontrolling interests | −26 | −30 | −14 | 0 | 0 | |
| Net income (loss) attributable to Century stockholders | 42 | 337 | −43 | −14 | −167 | |
| Less: Net income allocated to participating securities | 2 | 18 | 0 | 0 | — | |
| Net income (loss) allocated to common stockholders | 40 | 319 | −43 | −14 | −167 | |
| Basic (in dollars per share) | 0.42 | 3.44 | −0.47 | −0.15 | −1.85 | |
| Diluted (in dollars per share) | 0.42 | 3.27 | −0.47 | −0.15 | −1.85 | |
| Basic (in shares) | 94 | 93 | 92 | 91 | 90 | |
| Diluted (in shares) | 95 | 98 | 92 | 91 | 90 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2025 2025-09-30 | FY 2025 2025-06-30 | FY 2025 2025-03-31 | FY 2024 2024-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 134 | — | — | — | 33 | |
| Restricted cash | 1 | — | — | — | 3 | |
| Accounts receivable - net | 110 | — | — | — | 76 | |
| Non-trade receivables | 38 | 20 | 17 | 8 | 21 | |
| Manufacturing credit receivable | 173 | — | — | — | 82 | |
| Inventories | 520 | — | — | — | 539 | |
| Derivative assets | 2 | — | — | — | 4 | |
| Prepaid and other current assets | 24 | — | — | — | 28 | |
| Total current assets | 1,031 | 1,047 | 807 | 830 | 811 | |
| Property, plant and equipment - net | 1,168 | 1,139 | 1,151 | 1,142 | 1,150 | |
| Manufacturing credit receivable - less current portion | 0 | — | — | — | 70 | |
| Other assets | 70 | 72 | 71 | 70 | 89 | |
| TOTAL | 2,269 | 2,322 | 2,142 | 2,133 | 2,120 | |
| Accounts payable, trade | 187 | — | — | — | 187 | |
| Accrued compensation and benefits | 74 | 53 | 45 | 42 | 51 | |
| Due to affiliates | — | — | — | — | 109 | |
| Accrued and other current liabilities | 36 | 77 | 48 | 39 | 45 | |
| Derivative liabilities | 58 | — | — | — | 4 | |
| Carbon credit repurchase liability | 29 | — | — | — | 0 | |
| Total current liabilities | 524 | 592 | 448 | 444 | 467 | |
| Accrued benefits costs - less current portion | 98 | 136 | 142 | 144 | 145 | |
| Other liabilities | 105 | — | — | — | 93 | |
| Deferred taxes | 58 | — | — | — | 71 | |
| Asset retirement obligations - less current portion | 75 | 83 | 83 | 85 | 81 | |
| Total noncurrent liabilities | 816 | 872 | 847 | 852 | 847 | |
| COMMITMENTS AND CONTINGENCIES (Note 17) | — | — | — | — | — | |
| Preferred stock (Note 9) | 0 | — | — | — | 0 | |
| Common stock (Note 9) | 1 | — | — | — | 1 | |
| Additional paid-in capital | 2,572 | — | — | — | 2,550 | |
| Treasury stock, at cost | −86 | — | — | — | −86 | |
| Accumulated other comprehensive loss | −55 | — | — | — | −103 | |
| Accumulated deficit | −1,626 | — | — | — | −1,667 | |
| Total Century shareholders equity | 806 | — | — | — | 694 | |
| Noncontrolling interest | 124 | 117 | 123 | 112 | 111 | |
| Total equity | 930 | 859 | 847 | 838 | 805 | |
| TOTAL | 2,269 | 2,322 | 2,142 | 2,133 | 2,120 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Unrealized loss (gain) on derivative instruments | 63 | −5 | 87 | −202 | 103 | |
| Depreciation, depletion and amortization | 92 | 87 | 79 | 73 | 83 | |
| Share-based compensation | 47 | 15 | 7 | — | — | |
| Change in deferred tax provision | −14 | −1 | −31 | 44 | −31 | |
| Gain on sale of assets | 0 | −2 | 0 | 0 | — | |
| Force majeure settlement | 0 | −12 | 0 | 0 | — | |
| Lower of cost or NRV inventory adjustment | 9 | 2 | 0 | 40 | 0 | |
| Net periodic benefit cost | 12 | 16 | 14 | — | — | |
| Other non-cash items - net | 7 | −4 | −17 | −23 | −2 | |
| Accounts receivable - net | −24 | −18 | 37 | 14 | −16 | |
| Non-trade receivables | −2 | 23 | 4 | 0 | 0 | |
| Manufacturing credit receivable | −21 | −93 | −59 | 0 | 0 | |
| Due from affiliates | −5 | −5 | −16 | 4 | 700,000 | |
| Inventories | 11 | −64 | 26 | −13 | −135 | |
| Prepaid and other current assets | 4 | 1 | 3 | 6 | −13 | |
| Accounts payable, trade | 1 | −51 | −19 | −16 | 45 | |
| Due to affiliates | −13 | 26 | 52 | −44 | 38 | |
| Accrued and other current liabilities | 12 | 4 | 0 | 9 | 5 | |
| Ravenswood retiree medical settlement | −2 | −2 | −2 | — | — | |
| PBGC settlement | −2 | −300,000 | −5 | −2 | 0 | |
| Other - net | −13 | −2 | 3 | 1 | 2 | |
| Net cash provided by (used in) operating activities | 185 | −25 | 106 | 26 | −65 | |
| Capital expenditures | −100 | −82 | −95 | −86 | −83 | |
| Proceeds from sale of property, plant and equipment | 0 | 2 | 26 | 800,000 | 400,000 | |
| Acquisition of subsidiary net of cash acquired | 0 | 0 | 12 | 0 | 0 | |
| Net cash used in investing activities | −100 | −80 | −58 | −86 | −83 | |
| Repayment of Senior Notes due 2028 | −250 | 0 | 0 | 0 | 0 | |
| Early redemption premiums paid | −5 | 0 | 0 | 0 | −18 | |
| Proceeds from issuance of Senior Notes due 2032 | 400 | 0 | 0 | 0 | 250 | |
| Payment of deferred financing fees | −6 | 0 | 0 | −2 | −7 | |
| Contributions from joint venture partner | 20 | 13 | 0 | — | — | |
| Payments related to tax withholding for share-based compensation | −18 | 0 | 0 | — | — | |
| Carbon credit proceeds | 28 | 0 | 37 | 0 | 0 | |
| Carbon credit repayments | −28 | −10 | 0 | 0 | — | |
| Net cash provided by (used in) financing activities | 15 | 50 | −13 | 74 | 104 | |
| CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH | 100 | −55 | 35 | 15 | −44 | |
| Interest | 37 | 36 | 35 | 27 | 37 | |
| Income taxes, net of refunds | 5 | 15 | 6 | 900,000 | 3 | |
| Capital expenditures | 20 | 12 | 11 | 4 | 7 | |
| Capitalized interest | 0 | 3 | 6 | 4 | 2 |